XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Investments, at fair value    
Investments, at fair value $ 1,582,075 $ 1,262,956
Cash and cash equivalents 7,780 6,397
Restricted cash and cash equivalents 16,690 10,670
Interest and dividend receivable 14,000 9,945
Receivable from unsettled transactions 251 5
Unrealized appreciation on foreign currency forward contracts 5,128 8,154
Deferred tax assets 114 91
Other assets 1,341 4,660
Total assets 1,627,379 1,302,878
Liabilities    
Debt (net of deferred financing costs of $7,138 and $5,380) 844,783 654,456
Distributions payable 15,195 12,664
Interest and other debt financing costs payable 10,900 8,471
Management fees payable 5,026 4,056
Incentive fees payable 4,770 3,112
Deferred tax liabilities 578 899
Payable for investment purchased   514
Directors’ fees payable   151
Unrealized depreciation on foreign currency forward contracts 84 157
Accrued expenses and other liabilities 3,449 5,857
Total liabilities 884,785 690,337
Commitments and Contingencies (Note 8)
Net assets    
Common stock, par value $0.001 per share (200,000,000 shares authorized, 37,061,547 and 30,887,360 shares issued and outstanding, respectively) 37 31
Paid-in capital in excess of par value 965,895 675,008
Accumulated earnings (loss) (223,338) (62,498)
Total net assets 742,594 612,541
Total liabilities and net assets $ 1,627,379 $ 1,302,878
Net asset value per share $ 20.04 $ 19.83
Non-controlled non-affiliated    
Investments, at fair value    
Investments, at fair value $ 1,465,537 $ 1,208,501
Non-controlled affiliated    
Investments, at fair value    
Investments, at fair value 52,619 43,080
Controlled    
Investments, at fair value    
Investments, at fair value $ 63,919 $ 11,375